These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28929171)

  • 1. [Impact of European e-commerce liberalisation on pharmaceutical crime : The ALPhA research project].
    Sinn A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1245-1254. PubMed ID: 28929171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Operation Pangea - standing together in combat against international pharmaceutical crime].
    Smolka K; Gronwald K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1233-1239. PubMed ID: 28929174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Working Group of Enforcement Officers (WGEO) : The European Network of Drug Regulatory Authorities to Combat Pharmaceutical Crime].
    Wittstock M; Streit R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1228-1232. PubMed ID: 28980025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [European Network of Official Medicines Control Laboratories : International OMCL Working Group Combating Counterfeit and other Illegal Medicines].
    Wanko R; Unkelbach U
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1221-1227. PubMed ID: 28921172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Task force for falsified medicines].
    Weber G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1240-1244. PubMed ID: 28905078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Falsified medicines in parallel trade].
    Muckenfuß H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1208-1213. PubMed ID: 28905079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [securPharm e. V. - a protective shield against falsified medicines].
    Bergen M; Hoferichter R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1255-1260. PubMed ID: 28929207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current cases of falsified medicinal products within the competence of the Federal Institute for Drugs and Medical Devices (BfArM) : Case studies and extent].
    Wittstock M; Paeschke N
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1196-1202. PubMed ID: 28980029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Falsified pharmaceutical products : Legislative measures in the European Union and in Germany].
    Sträter B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1188-1195. PubMed ID: 28929177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Internet pharmacies and counterfeit drugs].
    Schweim JK; Schweim HG
    Med Klin (Munich); 2009 Feb; 104(2):163-9. PubMed ID: 19242667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Present Status of Displaying Pharmaceutical Products for Sale on Flea Market Applications for Smartphones and the Responses to Illicit Selling by Service Providers].
    Kishimoto K; Takeuchi T; Fukushima N
    Yakugaku Zasshi; 2017 Dec; 137(12):1533-1541. PubMed ID: 28883213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Counterfeit and contraband drugs in Brazil: overview and prospects for preventing their use].
    Hurtado RL; Lasmar MC
    Cad Saude Publica; 2014 Apr; 30(4):891-5. PubMed ID: 24896066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-counterfeit activities of pharmaceutical companies in Japan: for patient safety].
    Shofuda K; Aragane K; Igari Y; Matsumoto K; Ito K
    Yakugaku Zasshi; 2014; 134(2):203-11. PubMed ID: 24492224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The recovery of online drug markets following law enforcement and other disruptions.
    Van Buskirk J; Bruno R; Dobbins T; Breen C; Burns L; Naicker S; Roxburgh A
    Drug Alcohol Depend; 2017 Apr; 173():159-162. PubMed ID: 28259089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health.
    Mackey TK; Liang BA
    Global Health; 2013 Oct; 9():45. PubMed ID: 24131576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Counterfeit medicines--Japan and the world].
    Sato D
    Yakugaku Zasshi; 2014; 134(2):213-22. PubMed ID: 24492225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Counterfeit Medicines in Internet and the Fakeshare European Project: Experiences and Activities in Spain].
    Catalán-Matamoros D; González-Ochando N; Pecharroman-Arribas H; Fernández-Muelas A; Bentolila-Benchimol SS; IbarraLorente M
    Rev Esp Salud Publica; 2016 Aug; 90():e1-e14. PubMed ID: 27529446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The Herceptin® case : A case of falsification of medicinal products to a greater extent].
    Streit R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1203-1207. PubMed ID: 28936679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Campaign against counterfeit drugs].
    Warnet S
    Rev Infirm; 2013; (193):8. PubMed ID: 24245394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.